Atlas Trials

An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.

Clinical trial NCT07527832 · COMPLETED

Trial details

NCT number
NCT07527832
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Colorectal Cancer
Start date
2026-04-20
Primary completion
2026-05-27
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.